首页 > 最新文献

Current drug discovery technologies最新文献

英文 中文
A Computational Study of Famciclovir Derivatives Against Thymidine Kinase as a Molecular Target for the Development of Novel Anticancer Drugs via Suicide Gene Therapy Concepts. 基于自杀基因治疗概念的抗胸苷激酶泛昔洛韦衍生物的计算研究
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2023-01-01 DOI: 10.2174/1570163820666230509103455
Saravanan Thangavelu, Prabha Thangavelu, M R Pradeep Kumar, Sengotuvelu Singaravel, Lalitha Vivekanandan, Jagadeeswaran Murugesan, Sivakumar Thangavel

Background: The viral thymidine kinase (TK) phosphorylates the antiviral medication famciclovir (FCV), which treats herpes simplex virus (HSV-TK). The phosphorylated FCV destroys the infected cells by preventing cellular DNA synthesis.

Objective: We hypothesize that FCV impurity, which is a related substance to FCV, should be efficient in killing cells independent of HSV-TK and is currently the most widely used suicide agent for gene therapy of cancer.

Methods: This study proposes the binding affinity of these derivatives for the active site of TK through molecular docking to a protein (PDB ID: 1W4R). The derivatives' reliability was ensured through the in-silico preliminary drug designing model by screening their Lipinski rule of five violations, if any, ADMET prediction for their profile using online tools. Using MOE 2009.10 computational software, we performed molecular docking of approximately 22 famciclovir derivatives alongside the famciclovir drug.

Results: Our results suggest that these derivatives are indicative of possible chemical stability irrespective of all the parameters used to evaluate the selected derivatives as a possible drug candidates for their cytotoxicity. FC20 (i.e., 2-(2-(2-((1-(9-(4-Acetoxy-3-(acetoxymethyl)butyl)-2-amino-9Hpurin- 8-yl)ethyl)amino)-9H-purin-9-yl)ethyl)propane-1,3-diyl diacetate) and FC21 (i.e., 2-Amino-1,9- dihydro-9-(4-hydroxybutyl)-6H-purin-6-one), showed maximum and minimum scores of -26.95 and - 7.21 kcal/mol, respectively when compared to famciclovir (-15.4122 kcal/mol).

Conclusion: Considering that there might be a cytotoxicity effect due to competition between protein TK and the suicidal gene of famciclovir derivatives. The outcome of the study proved that the FCV impurity could successfully modify an HSV-TK-dependent antiviral drug into an anti-tumor drug. Further, it can be used for the design and development of novel compounds of FCV impurity that could be cytotoxic agents if properly delivered to cancer cells.

背景:病毒性胸苷激酶(TK)磷酸化抗病毒药物famciclovir (FCV),后者治疗单纯疱疹病毒(HSV-TK)。磷酸化的FCV通过阻止细胞DNA合成来破坏被感染的细胞。目的:我们推测FCV杂质是FCV的相关物质,它应该能有效地杀死不依赖于HSV-TK的细胞,是目前应用最广泛的癌症基因治疗自杀剂。方法:本研究提出了这些衍生物通过分子对接蛋白(PDB ID: 1W4R)与TK活性位点的结合亲和力。通过使用在线工具筛选其Lipinski规则(如果有的话),ADMET预测其特征,通过计算机初步药物设计模型确保了衍生物的可靠性。利用MOE 2009.10计算软件,我们进行了大约22个泛环洛韦衍生物与泛环洛韦药物的分子对接。结果:我们的研究结果表明,这些衍生物表明可能的化学稳定性,而不考虑用于评估所选衍生物作为可能的候选药物的细胞毒性的所有参数。FC20(即2-(2-(2-(2-(1-(9-(4-乙酰氧基-3-(乙酰氧基甲基)丁基)-2-氨基- 9hpurin - 8-基)乙基)氨基)- 9h -purin-9-基)乙基)丙烷-1,3-二乙酸二酯)和FC21(即2-氨基-1,9-二氢-9-(4-羟基丁基)- 6h -purin-6-one)与famciclovir (-15.4122 kcal/mol)相比,最高和最低分数分别为-26.95和- 7.21 kcal/mol。结论:考虑到泛环洛韦衍生物中TK蛋白与自杀基因的竞争可能存在细胞毒性作用。研究结果证明,FCV杂质可以成功地将hsv - tk依赖性抗病毒药物修饰为抗肿瘤药物。此外,它还可以用于设计和开发新型的FCV杂质化合物,如果适当地递送到癌细胞中,这些化合物可能是细胞毒性药物。
{"title":"A Computational Study of Famciclovir Derivatives Against Thymidine Kinase as a Molecular Target for the Development of Novel Anticancer Drugs <i>via</i> Suicide Gene Therapy Concepts.","authors":"Saravanan Thangavelu,&nbsp;Prabha Thangavelu,&nbsp;M R Pradeep Kumar,&nbsp;Sengotuvelu Singaravel,&nbsp;Lalitha Vivekanandan,&nbsp;Jagadeeswaran Murugesan,&nbsp;Sivakumar Thangavel","doi":"10.2174/1570163820666230509103455","DOIUrl":"https://doi.org/10.2174/1570163820666230509103455","url":null,"abstract":"<p><strong>Background: </strong>The viral thymidine kinase (TK) phosphorylates the antiviral medication famciclovir (FCV), which treats herpes simplex virus (HSV-TK). The phosphorylated FCV destroys the infected cells by preventing cellular DNA synthesis.</p><p><strong>Objective: </strong>We hypothesize that FCV impurity, which is a related substance to FCV, should be efficient in killing cells independent of HSV-TK and is currently the most widely used suicide agent for gene therapy of cancer.</p><p><strong>Methods: </strong>This study proposes the binding affinity of these derivatives for the active site of TK through molecular docking to a protein (PDB ID: 1W4R). The derivatives' reliability was ensured through the in-silico preliminary drug designing model by screening their Lipinski rule of five violations, if any, ADMET prediction for their profile using online tools. Using MOE 2009.10 computational software, we performed molecular docking of approximately 22 famciclovir derivatives alongside the famciclovir drug.</p><p><strong>Results: </strong>Our results suggest that these derivatives are indicative of possible chemical stability irrespective of all the parameters used to evaluate the selected derivatives as a possible drug candidates for their cytotoxicity. FC20 (i.e., 2-(2-(2-((1-(9-(4-Acetoxy-3-(acetoxymethyl)butyl)-2-amino-9Hpurin- 8-yl)ethyl)amino)-9H-purin-9-yl)ethyl)propane-1,3-diyl diacetate) and FC21 (i.e., 2-Amino-1,9- dihydro-9-(4-hydroxybutyl)-6H-purin-6-one), showed maximum and minimum scores of -26.95 and - 7.21 kcal/mol, respectively when compared to famciclovir (-15.4122 kcal/mol).</p><p><strong>Conclusion: </strong>Considering that there might be a cytotoxicity effect due to competition between protein TK and the suicidal gene of famciclovir derivatives. The outcome of the study proved that the FCV impurity could successfully modify an HSV-TK-dependent antiviral drug into an anti-tumor drug. Further, it can be used for the design and development of novel compounds of FCV impurity that could be cytotoxic agents if properly delivered to cancer cells.</p>","PeriodicalId":10858,"journal":{"name":"Current drug discovery technologies","volume":"20 5","pages":"e090523216693"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10137463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antifungal Effect of Carrot Carotenoids on Candida Species. 胡萝卜类胡萝卜素对念珠菌的抑菌作用。
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2023-01-01 DOI: 10.2174/1570163820666230227113802
Neda Askari, Mahboobeh Madani, Masoud Fouladgar, Pegah Shakib

Background: Candidiasis is a serious problem in women's health that is caused by Candida species, especially Candida albicans. In this study, the effect of carotenoids in carrot extracts on Candida species including Candida albicans ATCC1677, Candida glabrata CBS2175, Candida parapsilosis ATCC2195, and Candida tropicalis CBS94 was investigated.

Methods: In this descriptive study, the carrot plant was prepared from a carrot planting site in December 2012, and then the characteristics of the plant were determined. After extracting carotenoids from carrots, the susceptibility of different Candida species to carotenoids in carrot extract was determined. Also, the minimum inhibitory concentration and the minimum lethal concentration of the extracts were measured by the macro-dilution method. Finally, the data were analyzed by SPSS software using the Kruskal-Wallis test and Mann-Whitney post-hoc test with Bonferroni adjustment.

Results: The highest growth inhibition zone was obtained for carrot extract at a concentration of 500 mg/ml for C. glabrata and C. tropicalis. The MFC of carrot extract on Candida species was 62.5 mg/ml for C. albicans, C. glabrata, and C. parapsilosis, and 125 mg/ml for C. tropicalis. The MFC of carrot extract on Candida species was 125 mg/ml for C. albicans, C. glabrata, and C. parapsilosis, and 250 mg/ml for C. tropicalis.

Conclusion: The present study can be the starting point for research activities in this direction and promises new therapies based on the use of carotenoids.

背景:念珠菌病是由念珠菌引起的严重的妇女健康问题,尤其是白色念珠菌。本研究研究了胡萝卜提取物中类胡萝卜素对白色念珠菌ATCC1677、光滑念珠菌CBS2175、假丝酵母菌ATCC2195、热带念珠菌CBS94等念珠菌的影响。方法:采用描述性研究方法,于2012年12月在某胡萝卜种植场地制备胡萝卜植株,对其性状进行测定。从胡萝卜中提取类胡萝卜素,测定了不同念珠菌对胡萝卜提取物中类胡萝卜素的敏感性。并采用宏稀释法测定了各提取物的最小抑菌浓度和最小致死浓度。最后,采用SPSS软件进行Kruskal-Wallis检验和Mann-Whitney事后检验,并进行Bonferroni调整。结果:胡萝卜提取物浓度为500 mg/ml时,对光棘和热带棘的生长抑制带最大;胡萝卜提取物对白色念珠菌、光秃念珠菌和副念珠菌的MFC为62.5 mg/ml,对热带念珠菌的MFC为125 mg/ml。胡萝卜提取物对白色念珠菌、光秃念珠菌和副念珠菌的MFC为125 mg/ml,对热带念珠菌的MFC为250 mg/ml。结论:本研究为这一方向的研究提供了一个起点,并为基于类胡萝卜素的新疗法提供了希望。
{"title":"Antifungal Effect of Carrot Carotenoids on <i>Candida</i> Species.","authors":"Neda Askari,&nbsp;Mahboobeh Madani,&nbsp;Masoud Fouladgar,&nbsp;Pegah Shakib","doi":"10.2174/1570163820666230227113802","DOIUrl":"https://doi.org/10.2174/1570163820666230227113802","url":null,"abstract":"<p><strong>Background: </strong>Candidiasis is a serious problem in women's health that is caused by Candida species, especially Candida albicans. In this study, the effect of carotenoids in carrot extracts on Candida species including Candida albicans ATCC1677, Candida glabrata CBS2175, Candida parapsilosis ATCC2195, and Candida tropicalis CBS94 was investigated.</p><p><strong>Methods: </strong>In this descriptive study, the carrot plant was prepared from a carrot planting site in December 2012, and then the characteristics of the plant were determined. After extracting carotenoids from carrots, the susceptibility of different Candida species to carotenoids in carrot extract was determined. Also, the minimum inhibitory concentration and the minimum lethal concentration of the extracts were measured by the macro-dilution method. Finally, the data were analyzed by SPSS software using the Kruskal-Wallis test and Mann-Whitney post-hoc test with Bonferroni adjustment.</p><p><strong>Results: </strong>The highest growth inhibition zone was obtained for carrot extract at a concentration of 500 mg/ml for C. glabrata and C. tropicalis. The MFC of carrot extract on Candida species was 62.5 mg/ml for C. albicans, C. glabrata, and C. parapsilosis, and 125 mg/ml for C. tropicalis. The MFC of carrot extract on Candida species was 125 mg/ml for C. albicans, C. glabrata, and C. parapsilosis, and 250 mg/ml for C. tropicalis.</p><p><strong>Conclusion: </strong>The present study can be the starting point for research activities in this direction and promises new therapies based on the use of carotenoids.</p>","PeriodicalId":10858,"journal":{"name":"Current drug discovery technologies","volume":"20 3","pages":"e270223214066"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10153937","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Isolation of Bacillus amyloliquefaciens M13-RW0 from Soil and Evaluation of its Antifungal Activity. 从土壤中分离解淀粉芽孢杆菌M13-RW0及其抑菌活性评价
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2023-01-01 DOI: 10.2174/1570163820666230419090347
Shirin Naghdifar, Mahboobeh Madani, Pegah Shakib

Background: The frequency of observed invasive Aspergillosis has increased in recent years. Infection with other molds happens but does not lead to a large proportion of invasive infections. The present study aims to isolate Bacillus amyloliquefaciens M13-RW0 from soil and evaluate its antifungal effects against some saprophytic fungi, such as Aspergillus niger, Aspergillus flavus, and Mucor hiemalis.

Materials and methods: In this research, a total of 150 samples (from the soil, air, and surfaces) were prepared from different parts of Isfahan, Iran. Isolation and purification of growing bacteria were conducted using the nutrient agar medium. The inhibitory effects of 100 isolated bacteria were evaluated against the growth of A. niger, A. flavus, and M. hiemalis, 4 bacteria were isolated with inhibitory effects against the selected fungi, and consequently, one of the bacteria isolated from the soil samples was found to show the highest inhibition of fungal growth. Quantitative evaluation of the growth inhibitory effect was performed using linear culturing of fungal suspension (104 spore/ml) at distances of 5, 10, 15, 20, 25, and 30mm from bacterial isolate (0.5 McFarland) on Sabouraud Dextrose Agar (SDA) medium. Results were checked 24, 48, 72, and 96 hours later. The bacterial isolate with the most inhibitory effect was identified by phenotypic and molecular tests.

Results: According to the results, among the 4 inhibitory bacterial isolates, Bacillus amyloliquefaciens strain M13-RW01, isolated from the soil samples, was identified as the bacterium with the most significant potential antifungal activity. The strong inhibitory effect was revealed after 48 hours for all distances of 15mm and more between the fungi and the bacterium.

Conclusion: The identified bacterium could not only be considered an inhibitor bacterium against saprophytic fungi but could also be put forward to help produce new antifungal drugs for controlling fungal diseases.

背景:近年来侵袭性曲霉病的发病率有所上升。其他霉菌的感染会发生,但不会导致很大比例的侵袭性感染。本研究旨在从土壤中分离解淀粉芽孢杆菌M13-RW0,并评价其对一些腐生真菌,如黑曲霉、黄曲霉和毛霉的抑菌作用。材料和方法:在本研究中,从伊朗伊斯法罕的不同地区共制备了150个样品(来自土壤,空气和表面)。利用营养琼脂培养基对生长菌进行分离纯化。对100株分离细菌对黑曲霉、黄曲霉和黑曲霉生长的抑制作用进行了评价,分离到4株对所选真菌有抑制作用的细菌,结果发现从土壤样品中分离到的一株细菌对真菌生长的抑制作用最大。在Sabouraud Dextrose Agar (SDA)培养基上,用真菌悬浮液(104孢子/ml)在距离为5、10、15、20、25和30mm的地方进行线性培养,定量评估生长抑制效果。24小时、48小时、72小时和96小时后检查结果。通过表型和分子检测鉴定出抑菌效果最好的分离菌。结果:4株抑菌菌株中,从土壤样品中分离的解淀粉芽孢杆菌菌株M13-RW01为抑菌活性最显著的菌株。48小时后,真菌与细菌之间的距离在15mm及以上均有较强的抑制作用。结论:该细菌不仅可作为腐生真菌的抑制菌,而且可用于开发新的抗真菌药物来控制真菌疾病。
{"title":"Isolation of <i>Bacillus amyloliquefaciens</i> M13-RW0 from Soil and Evaluation of its Antifungal Activity.","authors":"Shirin Naghdifar,&nbsp;Mahboobeh Madani,&nbsp;Pegah Shakib","doi":"10.2174/1570163820666230419090347","DOIUrl":"https://doi.org/10.2174/1570163820666230419090347","url":null,"abstract":"<p><strong>Background: </strong>The frequency of observed invasive Aspergillosis has increased in recent years. Infection with other molds happens but does not lead to a large proportion of invasive infections. The present study aims to isolate Bacillus amyloliquefaciens M13-RW0 from soil and evaluate its antifungal effects against some saprophytic fungi, such as Aspergillus niger, Aspergillus flavus, and Mucor hiemalis.</p><p><strong>Materials and methods: </strong>In this research, a total of 150 samples (from the soil, air, and surfaces) were prepared from different parts of Isfahan, Iran. Isolation and purification of growing bacteria were conducted using the nutrient agar medium. The inhibitory effects of 100 isolated bacteria were evaluated against the growth of A. niger, A. flavus, and M. hiemalis, 4 bacteria were isolated with inhibitory effects against the selected fungi, and consequently, one of the bacteria isolated from the soil samples was found to show the highest inhibition of fungal growth. Quantitative evaluation of the growth inhibitory effect was performed using linear culturing of fungal suspension (10<sup>4</sup> spore/ml) at distances of 5, 10, 15, 20, 25, and 30mm from bacterial isolate (0.5 McFarland) on Sabouraud Dextrose Agar (SDA) medium. Results were checked 24, 48, 72, and 96 hours later. The bacterial isolate with the most inhibitory effect was identified by phenotypic and molecular tests.</p><p><strong>Results: </strong>According to the results, among the 4 inhibitory bacterial isolates, Bacillus amyloliquefaciens strain M13-RW01, isolated from the soil samples, was identified as the bacterium with the most significant potential antifungal activity. The strong inhibitory effect was revealed after 48 hours for all distances of 15mm and more between the fungi and the bacterium.</p><p><strong>Conclusion: </strong>The identified bacterium could not only be considered an inhibitor bacterium against saprophytic fungi but could also be put forward to help produce new antifungal drugs for controlling fungal diseases.</p>","PeriodicalId":10858,"journal":{"name":"Current drug discovery technologies","volume":"20 4","pages":"e190423216028"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9791101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Therapeutic Potential of Metformin-preconditioned Mesenchymal Stem Cells for Pancreatic Regeneration. 二甲双胍预处理间充质干细胞用于胰腺再生的治疗潜力。
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2023-01-01 DOI: 10.2174/1570163820666230309094233
Prajakta Kamble, Shivani Desai, Ramesh Bhonde, Avinash Sanap, Jagruti Shimpi, Rohit Kumbhar, Manesh Kokani, Avinash Kharat

Background: Diabetes occurs due to insulin deficiency or less insulin. To manage this condition, insulin administration as well as increased insulin sensitivity is required, but exogeneous insulin cannot replace the sensitive and gentle regulation of blood glucose levels same as β cells of healthy individuals. By considering the ability of regeneration and differentiation of stem cells, the current study planned to evaluate the effect of metformin preconditioned buccal fat pad (BFP) derived mesenchymal stem cells (MSCs) on streptozotocin (STZ) induced diabetes mellitus in Wistar rats.

Materials & methods: The disease condition was established by using a diabetes-inducing agent STZ in Wistar rats. Then, the animals were grouped into disease control, blank, and test groups. Only the test group received the metformin-preconditioned cells. The total study period for this experiment was 33 days. During this period, the animals were monitored for blood glucose level, body weight, and food-water intake twice a week. At the end of 33 days, the biochemical estimations for serum insulin level and pancreatic insulin level were performed. Also, histopathology of the pancreas, liver and skeletal muscle was performed.

Results: The test groups showed a decline in the blood glucose level and an increase in the serum pancreatic insulin level as compared to the disease group. No significant change in food and water intake was observed within the three groups, while body weight was significantly reduced in the test group when compared with the blank group, but the life span was increased when compared with the disease group.

Conclusion: In the present study, we concluded that metformin preconditioned buccal fat pad-derived mesenchymal stem cells have the ability to regenerate damaged pancreatic β cells and have antidiabetic activity, and this therapy is a better choice for future research.

背景:糖尿病是由于胰岛素缺乏或胰岛素不足而发生的。为了控制这种情况,胰岛素管理和胰岛素敏感性的增加是必需的,但是外源性胰岛素不能取代像健康人的β细胞一样对血糖水平的敏感和温和的调节。本研究拟从干细胞的再生和分化能力出发,评价二甲双胍预处理颊脂肪垫(BFP)源间充质干细胞(MSCs)对链脲佐菌素(STZ)诱导的Wistar大鼠糖尿病的影响。材料与方法:采用糖尿病诱导剂STZ建立Wistar大鼠的疾病状态。然后,将动物分为疾病控制组、空白组和试验组。只有实验组接受二甲双胍预处理的细胞。本试验的总研究期为33 d。在此期间,每周两次监测动物的血糖水平、体重和食物水摄入量。33 d结束时,进行血清胰岛素水平和胰腺胰岛素水平的生化测定。同时进行胰腺、肝脏和骨骼肌的组织病理学检查。结果:与疾病组相比,试验组血糖水平下降,血清胰胰岛素水平升高。三组间食物和水的摄取量均无明显变化,实验组体重较空白组明显减轻,但寿命较疾病组明显延长。结论:本研究认为二甲双胍预处理颊脂肪垫源性间充质干细胞具有胰腺β细胞再生能力和抗糖尿病活性,是今后研究的较好选择。
{"title":"Therapeutic Potential of Metformin-preconditioned Mesenchymal Stem Cells for Pancreatic Regeneration.","authors":"Prajakta Kamble,&nbsp;Shivani Desai,&nbsp;Ramesh Bhonde,&nbsp;Avinash Sanap,&nbsp;Jagruti Shimpi,&nbsp;Rohit Kumbhar,&nbsp;Manesh Kokani,&nbsp;Avinash Kharat","doi":"10.2174/1570163820666230309094233","DOIUrl":"https://doi.org/10.2174/1570163820666230309094233","url":null,"abstract":"<p><strong>Background: </strong>Diabetes occurs due to insulin deficiency or less insulin. To manage this condition, insulin administration as well as increased insulin sensitivity is required, but exogeneous insulin cannot replace the sensitive and gentle regulation of blood glucose levels same as β cells of healthy individuals. By considering the ability of regeneration and differentiation of stem cells, the current study planned to evaluate the effect of metformin preconditioned buccal fat pad (BFP) derived mesenchymal stem cells (MSCs) on streptozotocin (STZ) induced diabetes mellitus in Wistar rats.</p><p><strong>Materials & methods: </strong>The disease condition was established by using a diabetes-inducing agent STZ in Wistar rats. Then, the animals were grouped into disease control, blank, and test groups. Only the test group received the metformin-preconditioned cells. The total study period for this experiment was 33 days. During this period, the animals were monitored for blood glucose level, body weight, and food-water intake twice a week. At the end of 33 days, the biochemical estimations for serum insulin level and pancreatic insulin level were performed. Also, histopathology of the pancreas, liver and skeletal muscle was performed.</p><p><strong>Results: </strong>The test groups showed a decline in the blood glucose level and an increase in the serum pancreatic insulin level as compared to the disease group. No significant change in food and water intake was observed within the three groups, while body weight was significantly reduced in the test group when compared with the blank group, but the life span was increased when compared with the disease group.</p><p><strong>Conclusion: </strong>In the present study, we concluded that metformin preconditioned buccal fat pad-derived mesenchymal stem cells have the ability to regenerate damaged pancreatic β cells and have antidiabetic activity, and this therapy is a better choice for future research.</p>","PeriodicalId":10858,"journal":{"name":"Current drug discovery technologies","volume":"20 3","pages":"e090323214492"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9833316","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Repurposing Antipsychotic Agents Against Targets of Angiogenesis Pathways for Cancer Therapy: An in-silico Approach. 抗精神病药物对癌症治疗血管生成途径靶点的再利用:一种计算机方法。
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2023-01-01 DOI: 10.2174/1570163820666230606113158
Rahmon Kanmodi, Habeeb Bankole, Regina Oddiri, Michael Arowosegbe, Ridwan Alabi, Saheed Rahmon, Oladejo Ahmodu, Bilal AbdulRasheed, Rauf Muritala

Background: Antipsychotics interfere with virtually all hallmarks of cancer, including angiogenesis. Vascular endothelial growth factor receptors (VEGFRs) and platelet-derived growth receptors (PDGFRs) play crucial roles in angiogenesis and represent targets of many anti-cancer agents. We assessed and compared the binding effects of antipsychotics and receptor tyrosine kinase inhibitors (RTKIs) on VEGFR2 and PDGFRα.

Methods: FDA-approved antipsychotics and RTKIs were retrieved from DrugBank. VEGFR2 and PDGFRα structures were obtained from Protein Data Bank and loaded on Biovia Discovery Studio software to remove nonstandard molecules. Molecular docking was carried out using PyRx and CBDock to determine the binding affinities of protein-ligand complexes.

Results: Risperidone exerted the highest binding effect on PDGFRα (-11.0 Kcal/mol) as compared to other antipsychotic drugs and RTKIs. Risperidone also demonstrated a stronger binding effect on VEGFR2 (-9.6 Kcal/mol) than the RTKIs, pazopanib (-8.7 Kcal/mol), axitinib (-9.3 Kcal/mol), vandetanib (-8.3 Kcal/mol), lenvatinib ( -7.6 Kcal/mol) and sunitinib (-8.3 Kcal/mol). Sorafenib (an RTKI), however, exhibited the highest VEGFR2 binding affinity of -11.7 Kcal/mol.

Conclusion: Risperidone's superior binding affinity with PDGFRα when compared to all reference RTKIs and antipsychotic drugs, as well as its stronger binding effect on VEGFR2 over the RTKIs, sunitinib, pazopanib, axitinib, vandetanib, and lenvatinib, imply that it could be repurposed to inhibit angiogenic pathways and subjected to pre-clinical and clinical trials for cancer therapy.

背景:抗精神病药物几乎干扰癌症的所有特征,包括血管生成。血管内皮生长因子受体(VEGFR)和血小板衍生生长受体(PDGFRs)在血管生成中起着至关重要的作用,是许多抗癌药物的靶点。我们评估并比较了抗精神病药物和受体酪氨酸激酶抑制剂(RTKIs)对VEGFR2和PDGFRα的结合作用。VEGFR2和PDGFRα结构从蛋白质数据库获得,并加载在Biovia Discovery Studio软件上以去除非标准分子。使用PyRx和CBDock进行分子对接以确定蛋白质-配体复合物的结合亲和力。结果:与其他抗精神病药物和RTKIs相比,利培酮对PDGFRα的结合作用最高(-11.0 Kcal/mol)。利培酮对VEGFR2(-9.6千卡/摩尔)的结合作用也强于RTKIs、帕唑帕尼(-8.7千卡/mol)、阿西替尼(-9.3千卡/ol)、万德他尼(-8.3千卡-mol)、乐伐替尼(-7.6千卡-摩尔)和舒尼替尼(-8.3-千卡/莫尔)。然而,索拉非尼(一种RTKI)表现出最高的VEGFR2结合亲和力,为-11.7Kcal/mol。结论:与所有参考RTKI和抗精神病药物相比,利培酮与PDGFRα的结合亲和力更高,并且其对VEGFR2的结合作用强于RTKI、舒尼替尼、帕唑帕尼、阿西替尼、凡达替尼和乐伐替尼,意味着它可以被重新用于抑制血管生成途径,并进行癌症治疗的临床前和临床试验。
{"title":"Repurposing Antipsychotic Agents Against Targets of Angiogenesis Pathways for Cancer Therapy: An <i>in-silico</i> Approach.","authors":"Rahmon Kanmodi,&nbsp;Habeeb Bankole,&nbsp;Regina Oddiri,&nbsp;Michael Arowosegbe,&nbsp;Ridwan Alabi,&nbsp;Saheed Rahmon,&nbsp;Oladejo Ahmodu,&nbsp;Bilal AbdulRasheed,&nbsp;Rauf Muritala","doi":"10.2174/1570163820666230606113158","DOIUrl":"10.2174/1570163820666230606113158","url":null,"abstract":"<p><strong>Background: </strong>Antipsychotics interfere with virtually all hallmarks of cancer, including angiogenesis. Vascular endothelial growth factor receptors (VEGFRs) and platelet-derived growth receptors (PDGFRs) play crucial roles in angiogenesis and represent targets of many anti-cancer agents. We assessed and compared the binding effects of antipsychotics and receptor tyrosine kinase inhibitors (RTKIs) on VEGFR2 and PDGFRα.</p><p><strong>Methods: </strong>FDA-approved antipsychotics and RTKIs were retrieved from DrugBank. VEGFR2 and PDGFRα structures were obtained from Protein Data Bank and loaded on Biovia Discovery Studio software to remove nonstandard molecules. Molecular docking was carried out using PyRx and CBDock to determine the binding affinities of protein-ligand complexes.</p><p><strong>Results: </strong>Risperidone exerted the highest binding effect on PDGFRα (-11.0 Kcal/mol) as compared to other antipsychotic drugs and RTKIs. Risperidone also demonstrated a stronger binding effect on VEGFR2 (-9.6 Kcal/mol) than the RTKIs, pazopanib (-8.7 Kcal/mol), axitinib (-9.3 Kcal/mol), vandetanib (-8.3 Kcal/mol), lenvatinib ( -7.6 Kcal/mol) and sunitinib (-8.3 Kcal/mol). Sorafenib (an RTKI), however, exhibited the highest VEGFR2 binding affinity of -11.7 Kcal/mol.</p><p><strong>Conclusion: </strong>Risperidone's superior binding affinity with PDGFRα when compared to all reference RTKIs and antipsychotic drugs, as well as its stronger binding effect on VEGFR2 over the RTKIs, sunitinib, pazopanib, axitinib, vandetanib, and lenvatinib, imply that it could be repurposed to inhibit angiogenic pathways and subjected to pre-clinical and clinical trials for cancer therapy.</p>","PeriodicalId":10858,"journal":{"name":"Current drug discovery technologies","volume":" ","pages":"38-46"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9577959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Achievements in Hypothyroidism Treatment with Herbal Medicine: A Systematic Review of Randomized Controlled Trials. 中药治疗甲状腺功能减退的成果:随机对照试验的系统评价。
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2023-01-01 DOI: 10.2174/1570163820666230403091841
Najmeh Javidi, Zahra Mazloum Khorasani, Roshanak Salari, Shabnam Niroumand, Mahdi Yousefi

Background: Hypothyroidism is a common endocrine disease in the world that causes morbidity and mortality due to its association with metabolic diseases, especially in old age, and longterm treatment with levothyroxine causes many side effects for patients. Treatment with herbal medicine can regulate thyroid hormones and prevent side effects.

Objective: The purpose of this systematic review is the evaluation of the effect of herbal medicine on the signs and symptoms of primary hypothyroidism.

Methods: PubMed, Embase, Google Scholar, Scopus, and Cochrane Central Register of Controlled Trials were searched until 4 May, 2021. We selected randomized clinical trials (RCTs) that have assessed the effect of herbal medicine on hypothyroidism.

Results: Out of 771 articles, 4 trials with 186 participants were included. In one study, Nigella sativa L. caused a significant decrease in weight (P=0.004) and body mass index (BMI) (P=0.002). TSH levels were reported to be decreased and T3 increased in the treatment group (P =0.03) (P=0.008), respectively. In another study on Nigella sativa L., results did not show a significant difference between the two groups (p=0.02). A significant decrease in total cholesterol (CHL) and fasting blood sugar (FBS) was reported in participants with negative anti-thyroid peroxidase (anti-TPO) antibodies. In patients with positive anti-TPO antibodies, a significant increase in total cholesterol and FBS was observed in the intervention group (p=0.02). In the third RCT, T3 in the ashwagandha group at 4 and 8 weeks significantly increased by 18.6% (p=0.012) and 41.5% (p < 0.001), respectively. A noticeable increase was found in the T4 level from baseline by 9.3% (p= 0.002) and 19.6% (p < 0.001) at 4 and 8 weeks, respectively. TSH levels fell remarkably in the intervention group compared to placebo at 4 weeks (p <0.001) and 8 weeks (p <0.001), respectively. In the last article selected, Mentha x Piperita L. showed no significant difference in fatigue scores between intervention and control groups at the midpoint (day 7), while fatigue scores improved in the intervention group in all subscales compared to the control group on day 14.

Conclusion: Some herbal remedies, including Nigella sativa L., ashwagandha, and Mentha x Piperita L., can improve the signs and symptoms of primary hypothyroidism, but using a more extensive and advanced methodology will provide us with more complete results.

背景:甲状腺功能减退症是世界上常见的内分泌疾病,因其与代谢性疾病相关,发病率和死亡率高,尤其是在老年,长期使用左旋甲状腺素治疗会给患者带来许多副作用。用草药治疗可以调节甲状腺激素,防止副作用。目的:评价中药治疗原发性甲状腺功能减退症的临床疗效。方法:检索PubMed、Embase、Google Scholar、Scopus和Cochrane Central Register of Controlled Trials,直至2021年5月4日。我们选择了随机临床试验(rct)来评估草药治疗甲状腺功能减退的效果。结果:在771篇文章中,纳入了4项试验,共186名受试者。在一项研究中,黑草(Nigella sativa L.)引起体重(P=0.004)和体重指数(BMI) (P=0.002)的显著降低。治疗组TSH水平降低,T3水平升高(P= 0.03) (P=0.008)。在另一项对黑草的研究中,两组间的结果无显著差异(p=0.02)。据报道,在抗甲状腺过氧化物酶(抗tpo)抗体阴性的参与者中,总胆固醇(CHL)和空腹血糖(FBS)显著下降。在抗tpo抗体阳性的患者中,干预组总胆固醇和FBS显著升高(p=0.02)。在第三个RCT中,ashwagandha组在第4周和第8周T3分别显著增加18.6% (p=0.012)和41.5% (p < 0.001)。在4周和8周时,T4水平较基线分别显著增加9.3% (p= 0.002)和19.6% (p < 0.001)。与安慰剂相比,干预组的TSH水平在4周时显著下降(p)。结论:一些草药,包括黑草,印度胡椒和薄荷,可以改善原发性甲状腺功能减退症的体征和症状,但使用更广泛和更先进的方法将为我们提供更完整的结果。
{"title":"Achievements in Hypothyroidism Treatment with Herbal Medicine: A Systematic Review of Randomized Controlled Trials.","authors":"Najmeh Javidi,&nbsp;Zahra Mazloum Khorasani,&nbsp;Roshanak Salari,&nbsp;Shabnam Niroumand,&nbsp;Mahdi Yousefi","doi":"10.2174/1570163820666230403091841","DOIUrl":"https://doi.org/10.2174/1570163820666230403091841","url":null,"abstract":"<p><strong>Background: </strong>Hypothyroidism is a common endocrine disease in the world that causes morbidity and mortality due to its association with metabolic diseases, especially in old age, and longterm treatment with levothyroxine causes many side effects for patients. Treatment with herbal medicine can regulate thyroid hormones and prevent side effects.</p><p><strong>Objective: </strong>The purpose of this systematic review is the evaluation of the effect of herbal medicine on the signs and symptoms of primary hypothyroidism.</p><p><strong>Methods: </strong>PubMed, Embase, Google Scholar, Scopus, and Cochrane Central Register of Controlled Trials were searched until 4 May, 2021. We selected randomized clinical trials (RCTs) that have assessed the effect of herbal medicine on hypothyroidism.</p><p><strong>Results: </strong>Out of 771 articles, 4 trials with 186 participants were included. In one study, Nigella sativa L. caused a significant decrease in weight (P=0.004) and body mass index (BMI) (P=0.002). TSH levels were reported to be decreased and T3 increased in the treatment group (P =0.03) (P=0.008), respectively. In another study on Nigella sativa L., results did not show a significant difference between the two groups (p=0.02). A significant decrease in total cholesterol (CHL) and fasting blood sugar (FBS) was reported in participants with negative anti-thyroid peroxidase (anti-TPO) antibodies. In patients with positive anti-TPO antibodies, a significant increase in total cholesterol and FBS was observed in the intervention group (p=0.02). In the third RCT, T3 in the ashwagandha group at 4 and 8 weeks significantly increased by 18.6% (p=0.012) and 41.5% (p < 0.001), respectively. A noticeable increase was found in the T4 level from baseline by 9.3% (p= 0.002) and 19.6% (p < 0.001) at 4 and 8 weeks, respectively. TSH levels fell remarkably in the intervention group compared to placebo at 4 weeks (p <0.001) and 8 weeks (p <0.001), respectively. In the last article selected, Mentha x Piperita L. showed no significant difference in fatigue scores between intervention and control groups at the midpoint (day 7), while fatigue scores improved in the intervention group in all subscales compared to the control group on day 14.</p><p><strong>Conclusion: </strong>Some herbal remedies, including Nigella sativa L., ashwagandha, and Mentha x Piperita L., can improve the signs and symptoms of primary hypothyroidism, but using a more extensive and advanced methodology will provide us with more complete results.</p>","PeriodicalId":10858,"journal":{"name":"Current drug discovery technologies","volume":"20 5","pages":"e030423215393"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10190563","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biological Effects and Mechanisms of Taurine in Various Therapeutics. 牛磺酸在各种治疗中的生物学作用和机制。
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2023-01-01 DOI: 10.2174/1570163820666230525101353
Shikha Sharma, Biswa Mohan Sahoo, Bimal Krishna Banik

More than two hundred years ago, taurine was first isolated from materials derived from animals. It is abundantly found in a wide range of mammalian and non-mammalian tissues and diverse environments. Taurine was discovered to be a by-product of the metabolism of sulfur only a little over a century and a half ago. Recently, there has been a renewed academic interest in researching and exploring various uses of the amino acid taurine, and recent research has indicated that it may be useful in the treatment of a variety of disorders, including seizures, high blood pressure, cardiac infarction, neurodegeneration, and diabetes. Taurine is currently authorised for the therapy of congestive heart failure in Japan, and it has shown promising results in the management of several other illnesses as well. Moreover, it was found to be effective in some clinical trials, and hence it was patented for the same. This review compiles the research data that supports the prospective usage of taurine as an antibacterial, antioxidant, anti-inflammatory, diabetic, retinal protective, and membrane stabilizing agent, amongst other applications.

200多年前,牛磺酸首次从动物来源的物质中分离出来。它广泛存在于哺乳动物和非哺乳动物的组织和不同的环境中。一个半世纪前,人们才发现牛磺酸是硫代谢的副产物。最近,学术界对研究和探索氨基酸牛磺酸的各种用途重新产生了兴趣,最近的研究表明,它可能用于治疗各种疾病,包括癫痫发作、高血压、心肌梗死、神经退行性变和糖尿病。牛磺酸目前在日本被授权用于治疗充血性心力衰竭,它在治疗其他几种疾病方面也显示出了良好的效果。此外,它在一些临床试验中被发现是有效的,因此它也获得了专利。这篇综述汇编了支持牛磺酸作为抗菌、抗氧化剂、抗炎、糖尿病、视网膜保护剂和膜稳定剂等应用的研究数据。
{"title":"Biological Effects and Mechanisms of Taurine in Various Therapeutics.","authors":"Shikha Sharma,&nbsp;Biswa Mohan Sahoo,&nbsp;Bimal Krishna Banik","doi":"10.2174/1570163820666230525101353","DOIUrl":"10.2174/1570163820666230525101353","url":null,"abstract":"<p><p>More than two hundred years ago, taurine was first isolated from materials derived from animals. It is abundantly found in a wide range of mammalian and non-mammalian tissues and diverse environments. Taurine was discovered to be a by-product of the metabolism of sulfur only a little over a century and a half ago. Recently, there has been a renewed academic interest in researching and exploring various uses of the amino acid taurine, and recent research has indicated that it may be useful in the treatment of a variety of disorders, including seizures, high blood pressure, cardiac infarction, neurodegeneration, and diabetes. Taurine is currently authorised for the therapy of congestive heart failure in Japan, and it has shown promising results in the management of several other illnesses as well. Moreover, it was found to be effective in some clinical trials, and hence it was patented for the same. This review compiles the research data that supports the prospective usage of taurine as an antibacterial, antioxidant, anti-inflammatory, diabetic, retinal protective, and membrane stabilizing agent, amongst other applications.</p>","PeriodicalId":10858,"journal":{"name":"Current drug discovery technologies","volume":" ","pages":"60-78"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9524152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
An Overview of Pharmacological and Clinical Aspects of Spirulina. 螺旋藻的药理和临床研究综述。
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2023-01-01 DOI: 10.2174/1570163820666221129141217
Ramin Ansari, Mohammad Mehdi Zarshenas, Farzaneh Foroughinia, Amirhossein Dadbakhsh, Forough Afsari

Spirulina or Arthrospira, a Cyanobacterium from the class Cyanophyceae, with a wide range of properties, has been applied for over 400 years. The present study aimed to review available investigations surrounding the clinical and pharmacological properties of Spirulina that have been carried out so far. Databases including Scopus, PubMed, Google Scholar, and Web of Science were searched for relevant literature using the keywords: (Spirulina), (pharmacology), and (clinical). About 130 papers that studied the pharmacological characteristics of Spirulina in animal models, as well as clinical trials, were selected from the beginning to 29 July 2021. According to this review, antioxidative, anti-inflammatory, anti-neoplastic, hypolipidemic, antiviral, immunomodulatory, antimicrobial, anti-atherogenic, anti-diabetic, and radio-protective functions are attributed to Spirulina. Moreover, Spirulina's positive influence on several organs, including hair, skin, liver, CNS, lung, and genitourinary tract, are ascribed to different components of various species of Spirulina such as Spirulina platensis, Spirulina fusiformis, and Spirulina maxima. Although so many studies have been accomplished on every aspect of Spirulina in recent years, the lack of a comprehensive investigation surrounding this microalga encouraged us to prepare this paper. Therefore, the present study could be considered an up-to-date overview of the clinical, pharmacological, and molecular aspects of Spirulina, resulting in more occupational research on this valuable organism.

螺旋藻或节螺旋藻是蓝藻科的一种蓝藻,具有广泛的特性,已被应用了400多年。本研究的目的是审查现有的调查周围的临床和药理学性质的螺旋藻已经进行了迄今为止。检索关键词:(Spirulina)、(pharmacology)、(clinical),检索Scopus、PubMed、Google Scholar、Web of Science等数据库的相关文献。从2021年7月开始至29日,选取了约130篇研究螺旋藻在动物模型中的药理特性以及临床试验的论文。根据这篇综述,螺旋藻具有抗氧化、抗炎、抗肿瘤、降血脂、抗病毒、免疫调节、抗菌、抗动脉粥样硬化、抗糖尿病和辐射防护等功能。此外,螺旋藻对头发、皮肤、肝脏、中枢神经系统、肺、生殖泌尿道等多个器官的积极影响,归因于各种螺旋藻的不同成分,如:平螺旋藻、梭形螺旋藻、大螺旋藻。虽然近年来人们对螺旋藻的各个方面都进行了大量的研究,但由于缺乏对这种微藻的全面调查,我们决定准备这篇论文。因此,本研究可以被认为是螺旋藻临床、药理学和分子方面的最新综述,从而对这种有价值的生物进行更多的职业研究。
{"title":"An Overview of Pharmacological and Clinical Aspects of <i>Spirulina</i>.","authors":"Ramin Ansari,&nbsp;Mohammad Mehdi Zarshenas,&nbsp;Farzaneh Foroughinia,&nbsp;Amirhossein Dadbakhsh,&nbsp;Forough Afsari","doi":"10.2174/1570163820666221129141217","DOIUrl":"https://doi.org/10.2174/1570163820666221129141217","url":null,"abstract":"<p><p>Spirulina or Arthrospira, a Cyanobacterium from the class Cyanophyceae, with a wide range of properties, has been applied for over 400 years. The present study aimed to review available investigations surrounding the clinical and pharmacological properties of Spirulina that have been carried out so far. Databases including Scopus, PubMed, Google Scholar, and Web of Science were searched for relevant literature using the keywords: (Spirulina), (pharmacology), and (clinical). About 130 papers that studied the pharmacological characteristics of Spirulina in animal models, as well as clinical trials, were selected from the beginning to 29 July 2021. According to this review, antioxidative, anti-inflammatory, anti-neoplastic, hypolipidemic, antiviral, immunomodulatory, antimicrobial, anti-atherogenic, anti-diabetic, and radio-protective functions are attributed to Spirulina. Moreover, Spirulina's positive influence on several organs, including hair, skin, liver, CNS, lung, and genitourinary tract, are ascribed to different components of various species of Spirulina such as Spirulina platensis, Spirulina fusiformis, and Spirulina maxima. Although so many studies have been accomplished on every aspect of Spirulina in recent years, the lack of a comprehensive investigation surrounding this microalga encouraged us to prepare this paper. Therefore, the present study could be considered an up-to-date overview of the clinical, pharmacological, and molecular aspects of Spirulina, resulting in more occupational research on this valuable organism.</p>","PeriodicalId":10858,"journal":{"name":"Current drug discovery technologies","volume":"20 2","pages":"e291122211363"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10136007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Kidney Cancer and microRNAs as Novel Biomarkers and Tumor Suppressors. 肾癌和microrna作为新的生物标志物和肿瘤抑制因子。
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2023-01-01 DOI: 10.2174/1570163820666230110153608
Khojasteh Malekmohammad, Firouzeh Gholampour
{"title":"Kidney Cancer and microRNAs as Novel Biomarkers and Tumor Suppressors.","authors":"Khojasteh Malekmohammad,&nbsp;Firouzeh Gholampour","doi":"10.2174/1570163820666230110153608","DOIUrl":"https://doi.org/10.2174/1570163820666230110153608","url":null,"abstract":"<jats:sec>\u0000<jats:title />\u0000<jats:p />\u0000</jats:sec>","PeriodicalId":10858,"journal":{"name":"Current drug discovery technologies","volume":"20 3","pages":"e100123212531"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9768018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preparation of Zinc Oxide Nanoparticles Assisted by Okra Mucilage and Evaluation of its Biological Activities. 秋葵黏液辅助氧化锌纳米颗粒的制备及其生物活性评价。
Q3 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2023-01-01 DOI: 10.2174/1570163820666221201090006
Pegah Shakib, Seyedeh Zahra Mirzaei, Hamed Esmaeil Lashgarian, Reza Saki, Gholamreza Goudarzi, Sarah Alsallameh, Abdolrazagh Marzban, Kourosh Cheraghipour

Background: In this study, zinc oxide nanoparticles (ZnO-NPs) were biologically synthesized from Abelmoschus esculentus L. (Okra) mucilage fraction (OM).

Methods: Analytical techniques were employed to study the formation and properties of OM-ZnO NPs, including their morphology, shape, size distribution, and surface charges. Additionally, OM-ZnO NPs were assessed for their antimicrobial, antioxidant, and cytotoxic properties.

Results: UV-visible spectroscopy confirmed the formation of OM-ZnO NPs, evident by the appearance of an SPR peak at 368.8 nm. The FTIR spectroscopy demonstrated that OM functional groups contribute to the formation and stability of the NPs. Micrographs from TEM and SEM showed that OM-ZnO NPs ranged from 15-40 nm in diameter, whereas hydrodynamic diameter and surface charge values obtained from Zeta and DLS were 72.8 nm and 14.6 mv, respectively. XRD analysis indicated the OM-ZnO NPs were crystalline with a wurtzite structure and a crystallite size of 27.3 nm, while EDX revealed a zinc: oxygen ratio of 67.5:34. Further, the OM-ZnO NPs demonstrated significant antimicrobial activity in response to different types of bacteria. In the antioxidant assay, the OM-ZnO NPs scavenged DPPH with 68.6% of the efficiency of ascorbic acid (100%).

Conclusion: The present study demonstrated the cytotoxic efficacy of MO-ZnO NPs against MCF7 cells with an IC50 of 43.99 μg/ml. Overall, the green synthesis of ZnO NPs by OM was successful for many biological applications, such as antimicrobial, antioxidant, and anticancer. Moreover, OM-ZnO NPs can be applied as a biologically-derived nanotherapeutic agent.

背景:以秋葵(Abelmoschus esculentus L.,秋葵)粘液部分(OM)为原料,生物合成氧化锌纳米颗粒(ZnO-NPs)。方法:采用分析技术研究OM-ZnO纳米粒子的形成和性质,包括形貌、形状、尺寸分布和表面电荷。此外,对OM-ZnO NPs的抗菌、抗氧化和细胞毒性进行了评估。结果:紫外可见光谱证实了OM-ZnO NPs的形成,在368.8 nm处出现SPR峰。FTIR光谱分析表明,OM官能团参与了NPs的形成和稳定性。TEM和SEM的显微图显示,OM-ZnO纳米粒子的直径在15 ~ 40 nm之间,而Zeta和DLS的水动力直径和表面电荷值分别为72.8 nm和14.6 mv。XRD分析表明,OM-ZnO纳米粒子呈纤锌矿结构,晶粒尺寸为27.3 nm, EDX分析表明其锌氧比为67.5:34。此外,OM-ZnO NPs对不同类型的细菌表现出显著的抗菌活性。在抗氧化实验中,OM-ZnO NPs清除DPPH的效率为抗坏血酸的68.6%(100%)。结论:MO-ZnO NPs对MCF7细胞具有细胞毒作用,IC50为43.99 μg/ml。综上所述,OM绿色合成ZnO NPs在抗菌、抗氧化和抗癌等生物领域的应用是成功的。此外,OM-ZnO纳米粒子可以作为生物来源的纳米治疗剂。
{"title":"Preparation of Zinc Oxide Nanoparticles Assisted by Okra Mucilage and Evaluation of its Biological Activities.","authors":"Pegah Shakib,&nbsp;Seyedeh Zahra Mirzaei,&nbsp;Hamed Esmaeil Lashgarian,&nbsp;Reza Saki,&nbsp;Gholamreza Goudarzi,&nbsp;Sarah Alsallameh,&nbsp;Abdolrazagh Marzban,&nbsp;Kourosh Cheraghipour","doi":"10.2174/1570163820666221201090006","DOIUrl":"https://doi.org/10.2174/1570163820666221201090006","url":null,"abstract":"<p><strong>Background: </strong>In this study, zinc oxide nanoparticles (ZnO-NPs) were biologically synthesized from Abelmoschus esculentus L. (Okra) mucilage fraction (OM).</p><p><strong>Methods: </strong>Analytical techniques were employed to study the formation and properties of OM-ZnO NPs, including their morphology, shape, size distribution, and surface charges. Additionally, OM-ZnO NPs were assessed for their antimicrobial, antioxidant, and cytotoxic properties.</p><p><strong>Results: </strong>UV-visible spectroscopy confirmed the formation of OM-ZnO NPs, evident by the appearance of an SPR peak at 368.8 nm. The FTIR spectroscopy demonstrated that OM functional groups contribute to the formation and stability of the NPs. Micrographs from TEM and SEM showed that OM-ZnO NPs ranged from 15-40 nm in diameter, whereas hydrodynamic diameter and surface charge values obtained from Zeta and DLS were 72.8 nm and 14.6 mv, respectively. XRD analysis indicated the OM-ZnO NPs were crystalline with a wurtzite structure and a crystallite size of 27.3 nm, while EDX revealed a zinc: oxygen ratio of 67.5:34. Further, the OM-ZnO NPs demonstrated significant antimicrobial activity in response to different types of bacteria. In the antioxidant assay, the OM-ZnO NPs scavenged DPPH with 68.6% of the efficiency of ascorbic acid (100%).</p><p><strong>Conclusion: </strong>The present study demonstrated the cytotoxic efficacy of MO-ZnO NPs against MCF7 cells with an IC50 of 43.99 μg/ml. Overall, the green synthesis of ZnO NPs by OM was successful for many biological applications, such as antimicrobial, antioxidant, and anticancer. Moreover, OM-ZnO NPs can be applied as a biologically-derived nanotherapeutic agent.</p>","PeriodicalId":10858,"journal":{"name":"Current drug discovery technologies","volume":"20 2","pages":"e011222211472"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9833291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current drug discovery technologies
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1